Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice
OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expres...
Gespeichert in:
Veröffentlicht in: | Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 83 |
---|---|
container_issue | 1 |
container_start_page | 75 |
container_title | Arteriosclerosis, thrombosis, and vascular biology |
container_volume | 37 |
creator | Chen, Xingjuan Qian, Shaomin Hoggatt, April Tang, Hongying Hacker, Timothy A Obukhov, Alexander G Herring, Paul B Seye, Cheikh I |
description | OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis.
APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants.
CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration. |
doi_str_mv | 10.1161/ATVBAHA.116.308561 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5268079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1841799142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</originalsourceid><addsrcrecordid>eNpVkc9u1DAQxiMEon_gBTggH7mk2E5iby5IYdlSpLas2ILEyXKcCWuYjYPtUPWAxDvwhjwJjnZBcPF4PD9_o5kvy54wesaYYM-bmw8vm4tmTs4KuqgEu5cds4qXeSkKcT_dqazzSpT8KDsJ4TOltOScPsyOuEx0WZXH2ffV0Lm4BbQayRIQf_34uRnB2N4a8goQonUDcT1Z84-cvAMDY3SerL3buQiBrFF_nYBsom4t2nhH7ECapOddMDifNuSbKczfbItAmtGt8usJkVxZA4-yB73GAI8P8TR7f766WV7kl29fv1k2l7nhUrK872kNmnd12XadLupCQ0XbihqWnqHVrOe9qOvWaNMKkJrLSstWcqEXkJiqOM1e7HXHqd1BZ2CIXqMavd1pf6ectur_ymC36pP7piouFmmJSeDZQcC7NG-IamfTUIh6ADcFxRYlk3XNSp7Qp__2-tvkz84TIPbArcMIPnzB6Ra82oLGuFWMqtlcdTB3TtTe3OI3XIGaYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1841799142</pqid></control><display><type>article</type><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</creator><creatorcontrib>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</creatorcontrib><description>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis.
APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants.
CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.116.308561</identifier><identifier>PMID: 27856454</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Animals ; Aorta, Thoracic - drug effects ; Aorta, Thoracic - metabolism ; Aorta, Thoracic - pathology ; Aorta, Thoracic - physiopathology ; Aortic Diseases - genetics ; Aortic Diseases - metabolism ; Aortic Diseases - pathology ; Aortic Diseases - prevention & control ; Apolipoproteins E - deficiency ; Apolipoproteins E - genetics ; Atherosclerosis - genetics ; Atherosclerosis - metabolism ; Atherosclerosis - pathology ; Atherosclerosis - prevention & control ; Cell Movement ; Cells, Cultured ; Collagen - metabolism ; Disease Models, Animal ; Disease Progression ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Fibrosis ; Macrophages - metabolism ; Macrophages - pathology ; Male ; Matrix Metalloproteinase 2 - metabolism ; Mice, Inbred C57BL ; Mice, Knockout ; Muscle, Smooth, Vascular - metabolism ; Muscle, Smooth, Vascular - pathology ; Muscle, Smooth, Vascular - physiopathology ; Myocytes, Smooth Muscle - metabolism ; Myocytes, Smooth Muscle - pathology ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - metabolism ; Plaque, Atherosclerotic ; Purinergic P2Y Receptor Agonists - pharmacology ; Receptors, Purinergic P2Y2 - deficiency ; Receptors, Purinergic P2Y2 - genetics ; Rupture, Spontaneous ; Signal Transduction ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83</ispartof><rights>2017 American Heart Association, Inc.</rights><rights>2016 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27856454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Xingjuan</creatorcontrib><creatorcontrib>Qian, Shaomin</creatorcontrib><creatorcontrib>Hoggatt, April</creatorcontrib><creatorcontrib>Tang, Hongying</creatorcontrib><creatorcontrib>Hacker, Timothy A</creatorcontrib><creatorcontrib>Obukhov, Alexander G</creatorcontrib><creatorcontrib>Herring, Paul B</creatorcontrib><creatorcontrib>Seye, Cheikh I</creatorcontrib><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis.
APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants.
CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</description><subject>Animals</subject><subject>Aorta, Thoracic - drug effects</subject><subject>Aorta, Thoracic - metabolism</subject><subject>Aorta, Thoracic - pathology</subject><subject>Aorta, Thoracic - physiopathology</subject><subject>Aortic Diseases - genetics</subject><subject>Aortic Diseases - metabolism</subject><subject>Aortic Diseases - pathology</subject><subject>Aortic Diseases - prevention & control</subject><subject>Apolipoproteins E - deficiency</subject><subject>Apolipoproteins E - genetics</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - metabolism</subject><subject>Atherosclerosis - pathology</subject><subject>Atherosclerosis - prevention & control</subject><subject>Cell Movement</subject><subject>Cells, Cultured</subject><subject>Collagen - metabolism</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Fibrosis</subject><subject>Macrophages - metabolism</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Matrix Metalloproteinase 2 - metabolism</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Muscle, Smooth, Vascular - physiopathology</subject><subject>Myocytes, Smooth Muscle - metabolism</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Plaque, Atherosclerotic</subject><subject>Purinergic P2Y Receptor Agonists - pharmacology</subject><subject>Receptors, Purinergic P2Y2 - deficiency</subject><subject>Receptors, Purinergic P2Y2 - genetics</subject><subject>Rupture, Spontaneous</subject><subject>Signal Transduction</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc9u1DAQxiMEon_gBTggH7mk2E5iby5IYdlSpLas2ILEyXKcCWuYjYPtUPWAxDvwhjwJjnZBcPF4PD9_o5kvy54wesaYYM-bmw8vm4tmTs4KuqgEu5cds4qXeSkKcT_dqazzSpT8KDsJ4TOltOScPsyOuEx0WZXH2ffV0Lm4BbQayRIQf_34uRnB2N4a8goQonUDcT1Z84-cvAMDY3SerL3buQiBrFF_nYBsom4t2nhH7ECapOddMDifNuSbKczfbItAmtGt8usJkVxZA4-yB73GAI8P8TR7f766WV7kl29fv1k2l7nhUrK872kNmnd12XadLupCQ0XbihqWnqHVrOe9qOvWaNMKkJrLSstWcqEXkJiqOM1e7HXHqd1BZ2CIXqMavd1pf6ectur_ymC36pP7piouFmmJSeDZQcC7NG-IamfTUIh6ADcFxRYlk3XNSp7Qp__2-tvkz84TIPbArcMIPnzB6Ra82oLGuFWMqtlcdTB3TtTe3OI3XIGaYg</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Chen, Xingjuan</creator><creator>Qian, Shaomin</creator><creator>Hoggatt, April</creator><creator>Tang, Hongying</creator><creator>Hacker, Timothy A</creator><creator>Obukhov, Alexander G</creator><creator>Herring, Paul B</creator><creator>Seye, Cheikh I</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201701</creationdate><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><author>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Aorta, Thoracic - drug effects</topic><topic>Aorta, Thoracic - metabolism</topic><topic>Aorta, Thoracic - pathology</topic><topic>Aorta, Thoracic - physiopathology</topic><topic>Aortic Diseases - genetics</topic><topic>Aortic Diseases - metabolism</topic><topic>Aortic Diseases - pathology</topic><topic>Aortic Diseases - prevention & control</topic><topic>Apolipoproteins E - deficiency</topic><topic>Apolipoproteins E - genetics</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - metabolism</topic><topic>Atherosclerosis - pathology</topic><topic>Atherosclerosis - prevention & control</topic><topic>Cell Movement</topic><topic>Cells, Cultured</topic><topic>Collagen - metabolism</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Fibrosis</topic><topic>Macrophages - metabolism</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Matrix Metalloproteinase 2 - metabolism</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Muscle, Smooth, Vascular - physiopathology</topic><topic>Myocytes, Smooth Muscle - metabolism</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Plaque, Atherosclerotic</topic><topic>Purinergic P2Y Receptor Agonists - pharmacology</topic><topic>Receptors, Purinergic P2Y2 - deficiency</topic><topic>Receptors, Purinergic P2Y2 - genetics</topic><topic>Rupture, Spontaneous</topic><topic>Signal Transduction</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xingjuan</creatorcontrib><creatorcontrib>Qian, Shaomin</creatorcontrib><creatorcontrib>Hoggatt, April</creatorcontrib><creatorcontrib>Tang, Hongying</creatorcontrib><creatorcontrib>Hacker, Timothy A</creatorcontrib><creatorcontrib>Obukhov, Alexander G</creatorcontrib><creatorcontrib>Herring, Paul B</creatorcontrib><creatorcontrib>Seye, Cheikh I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xingjuan</au><au>Qian, Shaomin</au><au>Hoggatt, April</au><au>Tang, Hongying</au><au>Hacker, Timothy A</au><au>Obukhov, Alexander G</au><au>Herring, Paul B</au><au>Seye, Cheikh I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2017-01</date><risdate>2017</risdate><volume>37</volume><issue>1</issue><spage>75</spage><epage>83</epage><pages>75-83</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><abstract>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis.
APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants.
CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>27856454</pmid><doi>10.1161/ATVBAHA.116.308561</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-5642 |
ispartof | Arteriosclerosis, thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83 |
issn | 1079-5642 1524-4636 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5268079 |
source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
subjects | Animals Aorta, Thoracic - drug effects Aorta, Thoracic - metabolism Aorta, Thoracic - pathology Aorta, Thoracic - physiopathology Aortic Diseases - genetics Aortic Diseases - metabolism Aortic Diseases - pathology Aortic Diseases - prevention & control Apolipoproteins E - deficiency Apolipoproteins E - genetics Atherosclerosis - genetics Atherosclerosis - metabolism Atherosclerosis - pathology Atherosclerosis - prevention & control Cell Movement Cells, Cultured Collagen - metabolism Disease Models, Animal Disease Progression Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelial Cells - pathology Fibrosis Macrophages - metabolism Macrophages - pathology Male Matrix Metalloproteinase 2 - metabolism Mice, Inbred C57BL Mice, Knockout Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology Muscle, Smooth, Vascular - physiopathology Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology Nitric Oxide - metabolism Nitric Oxide Synthase Type III - metabolism Plaque, Atherosclerotic Purinergic P2Y Receptor Agonists - pharmacology Receptors, Purinergic P2Y2 - deficiency Receptors, Purinergic P2Y2 - genetics Rupture, Spontaneous Signal Transduction Vasodilation - drug effects Vasodilator Agents - pharmacology |
title | Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A16%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20Cell%E2%80%93Specific%20Deletion%20of%20P2Y2%20Receptor%20Promotes%20Plaque%20Stability%20in%20Atherosclerosis-Susceptible%20ApoE-Null%20Mice&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Chen,%20Xingjuan&rft.date=2017-01&rft.volume=37&rft.issue=1&rft.spage=75&rft.epage=83&rft.pages=75-83&rft.issn=1079-5642&rft.eissn=1524-4636&rft_id=info:doi/10.1161/ATVBAHA.116.308561&rft_dat=%3Cproquest_pubme%3E1841799142%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1841799142&rft_id=info:pmid/27856454&rfr_iscdi=true |